Suppr超能文献

基于互联网和移动的亚临床焦虑和抑郁干预的疗效(ICare Prevent),采用两种指导形式:一项三臂随机对照试验的结果。

Efficacy of an Internet- and Mobile-Based Intervention for Subclinical Anxiety and Depression (ICare Prevent) with Two Guidance Formats: Results from a Three-Armed Randomized Controlled Trial.

机构信息

Division of eHealth in Clinical Psychology, Department of Clinical Psychology, Philipps University of Marburg, Marburg, Germany.

Department of Clinical Psychology and Psychotherapy, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.

出版信息

Psychother Psychosom. 2024;93(3):155-168. doi: 10.1159/000536149. Epub 2024 Apr 30.

Abstract

INTRODUCTION

Limited research exists on intervention efficacy for comorbid subclinical anxiety and depressive disorders, despite their common co-occurrence. Internet- and mobile-based interventions (IMIs) are promising to reach individuals facing subclinical symptoms.

OBJECTIVE

This study aimed to evaluate the efficacy of a transdiagnostic and self-tailored IMI in reducing subclinical anxiety and depressive symptom severity with either individualized (IG-IMI) or automated (AG-IMI) guidance compared to a waitlist control group with care-as-usual access (WLC).

METHODS

Participants included 566 adults with subclinical anxiety (GAD-7 ≥ 5) and/or depressive (CES-D ≥16) symptoms, who did not meet criteria for a full-syndrome depressive or anxiety disorder. In a three-arm randomized clinical trial, participants were randomized to a cognitive behavioral 7-session IMI plus booster session with IG-IMI (n = 186) or AG-IMI (n = 189) or WLC (n = 191). Primary outcomes included observer-rated anxiety (HAM-A) and depressive (QIDS) symptom severity 8 weeks after randomization assessed by blinded raters via telephone. Follow-up outcomes at 6 and 12 months are reported.

RESULTS

Symptom severity was significantly lower with small to medium effects in IG-IMI (anxiety: d = 0.45, depression: d = 0.43) and AG-IMI (anxiety: d = 0.31, depression: d = 0.32) compared to WLC. No significant differences emerged between guidance formats in primary outcomes. There was a significant effect in HAM-A after 6 months favoring AG-IMI. On average, participants completed 85.38% of IG-IMI and 77.38% of AG-IMI.

CONCLUSIONS

A transdiagnostic, self-tailored IMI can reduce subclinical anxiety and depressive symptom severity, but 12-month long-term effects were absent. Automated guidance holds promise for enhancing the scalability of IMIs in broad prevention initiatives.

摘要

简介

尽管亚临床焦虑和抑郁障碍经常同时发生,但针对这些共病的干预效果的研究还很有限。基于互联网和移动的干预措施(IMIs)有望为面临亚临床症状的个体提供帮助。

目的

本研究旨在评估一种跨诊断和自我定制的 IMI 在减少亚临床焦虑和抑郁症状严重程度方面的疗效,该 IMI 采用个体化指导(IG-IMI)或自动化指导(AG-IMI),与提供常规护理的等待名单对照组(WLC)相比。

方法

参与者包括 566 名有亚临床焦虑(GAD-7≥5)和/或抑郁(CES-D≥16)症状但不符合全面综合征性抑郁或焦虑障碍标准的成年人。在一项三臂随机临床试验中,参与者被随机分配到一个认知行为 7 节 IMI 加强化课程,分别接受 IG-IMI(n=186)或 AG-IMI(n=189)或 WLC(n=191)的治疗。主要结局包括在随机分组后 8 周通过电话由盲法评估者评估的焦虑(HAM-A)和抑郁(QIDS)症状严重程度。报告了 6 个月和 12 个月的随访结局。

结果

与 WLC 相比,IG-IMI(焦虑:d=0.45,抑郁:d=0.43)和 AG-IMI(焦虑:d=0.31,抑郁:d=0.32)的症状严重程度显著降低,且具有较小到中等的效果。两种指导方式在主要结局上没有显著差异。AG-IMI 在 6 个月时在 HAM-A 上的效果显著更好。平均而言,参与者完成了 IG-IMI 的 85.38%和 AG-IMI 的 77.38%。

结论

一种跨诊断、自我定制的 IMI 可以降低亚临床焦虑和抑郁症状的严重程度,但 12 个月的长期效果并不存在。自动化指导有望增强 IMIs 在广泛的预防计划中的可扩展性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc47/11151970/75491fc45382/pps-2024-0093-0003-536149_F01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验